Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Kniess

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Synthesis and radiopharmacological evaluation of 2'-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11beta,17alpha-dihydroxy-pregn-4-eno[3,2-c]pyrazole as potential glucocorticoid receptor ligand for positron emission tomography (PET)Frank Wüst, Torsten Kniess, Marion Kretzschmar, et al.
Molecules (Basel, Switzerland)|October 27, 2019
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-<i>hi</i>]indoles and Their Potential ProdrugsMarkus Laube, Cemena Gassner, Torsten Kniess, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 17, 2011
Radiolabeling of phosphatidylserine-binding peptides with prosthetic groups N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM) and N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)Janice Kapty, Torsten Kniess, Frank Wuest, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptorsFrank Wuest, Torsten Kniess, Ralf Bergmann, et al.
Bioorganic & Medicinal Chemistry|January 23, 2009
Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivativesFrank Wuest, Xinli Tang, Torsten Kniess, et al.
Clinical Hemorheology and Microcirculation|October 24, 2014
Organotypical vascular model for characterization of radioprotective compounds: studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitorsSandra Ullm, Markus Laube, Nicole Bechmann, et al.
Chemical Communications (Cambridge, England)|December 22, 2009
Radiolabelling of proteins with fluorine-18 via click chemistryTheres Ramenda, Torsten Kniess, Ralf Bergmann, et al.
Bioorganic & Medicinal Chemistry|October 14, 2009
Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitorTorsten Kniess, Ralf Bergmann, Manuela Kuchar, et al.
Mini Reviews in Medicinal Chemistry|June 10, 2008
Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET)Björn Steiniger, Torsten Kniess, Ralf Bergmann, et al.
Clinical Hemorheology and Microcirculation|December 31, 2014
Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitroJens Pietzsch, Markus Laube, Nicole Bechmann, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Synthesis and radiopharmacological evaluation of 2'-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11beta,17alpha-dihydroxy-pregn-4-eno[3,2-c]pyrazole as potential glucocorticoid receptor ligand for positron emission tomography (PET)Frank Wüst, Torsten Kniess, Marion Kretzschmar, et al.
Molecules (Basel, Switzerland)|October 27, 2019
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-<i>hi</i>]indoles and Their Potential ProdrugsMarkus Laube, Cemena Gassner, Torsten Kniess, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 17, 2011
Radiolabeling of phosphatidylserine-binding peptides with prosthetic groups N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM) and N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)Janice Kapty, Torsten Kniess, Frank Wuest, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptorsFrank Wuest, Torsten Kniess, Ralf Bergmann, et al.
Bioorganic & Medicinal Chemistry|January 23, 2009
Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivativesFrank Wuest, Xinli Tang, Torsten Kniess, et al.
Clinical Hemorheology and Microcirculation|October 24, 2014
Organotypical vascular model for characterization of radioprotective compounds: studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitorsSandra Ullm, Markus Laube, Nicole Bechmann, et al.
Chemical Communications (Cambridge, England)|December 22, 2009
Radiolabelling of proteins with fluorine-18 via click chemistryTheres Ramenda, Torsten Kniess, Ralf Bergmann, et al.
Bioorganic & Medicinal Chemistry|October 14, 2009
Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitorTorsten Kniess, Ralf Bergmann, Manuela Kuchar, et al.
Mini Reviews in Medicinal Chemistry|June 10, 2008
Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET)Björn Steiniger, Torsten Kniess, Ralf Bergmann, et al.
Clinical Hemorheology and Microcirculation|December 31, 2014
Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitroJens Pietzsch, Markus Laube, Nicole Bechmann, et al.
Pageof 5